Zusammenfassung
Die Magnetresonanztomographie (MRT) hat die Computertomographie (CT) in der Diagnostik
von Karzinomen des Uterus (Endometrium- und Zervixkarzinom) vollständig abgelöst.
Die Stadieneinteilung eines Endometriumkarzinoms, insbesondere auch die Beurteilung
der myometranen Infiltrationstiefe, ist vor allem mit der Kontrastmittel-unterstützten
MRT mit hoher Treffsicherheit möglich. Die MRT bietet zukünftig eine gute Basis für
die präoperative Therapieplanung, insbesondere im Hinblick auf die Frage, ob eine
Lymphadenektomie in Abhängigkeit von der myometranen Infiltrationstiefe erforderlich
scheint oder nicht. - Der vorliegende Artikel skizziert die Möglichkeiten der MRT
für das Staging des Endometriumkarzinoms, beschreibt kurz die erforderliche Untersuchungsstrategie
und analysiert den diagnostischen Stellenwert der MRT in der Diagnostik des Endometriumkarzinoms.
Summary
Magnetic resonance (MR) imaging has superseded computed tomography (CT) in the diagnostic
assessment of cancer of the uterus (endometrial and cervical carcinoma). Contrast-enhanced
MR imaging is highly accurate in staging endometrial carcinoma, in particular in terms
of the depth of myometrial invasion. MR imaging will in the future provide a good
basis for preoperative therapeutic decision making, especially to answer the question
whether or not lymphadenectomy is necessary based on myometrial infiltration depth.
- This article outlines the potential of MR imaging for staging endometrial cancer,
provides a brief description of the imaging strategies, and discusses the role of
MR imaging in the diagnostic assessment of endometrial cancer.
Schlüsselwörter
Endometriumkarzinom - Kernspintomographie - Computertomographie - Gadolinium-DTPA
Key words
Endometrial carcinoma - MR imaging - Computed tomography - Gadolinium-DTPA
Literatur
- 1
Hricak H, Rubinstein L V, Gherman G M, Karstaedt N.
MR imaging evaluation of endometrial carcinoma: Results of an NCI cooperative study.
Radiology.
1991;
179
829-832
- 2
Scoutt L M, McCarthy S M, Flynn S D, Lange R C, Long F, Smith R C, Chambers S K, Kohorn E,
Schwartz P, Chambers J T.
Clinical stage I endometrial carcinoma: Pitfalls in preoperative assessment with MR
imaging.
Radiology.
1995;
194
567-572
- 3
Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, DelMaschio A.
Myometrial invasion by endometrial carcinoma: Assessment with plain and gadolinium-enhanced
MR imaging.
Radiology.
1992;
185
207-212
- 4
Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H.
Normal uterus and FIGO stage I endometrial carcinoma: Dynamic gadolinium-enhanced
MR imaging.
Radiology.
1993;
186
495-501
- 5
Savci G, Ozyaman T, Tutar M, Bilgin T, Erol O, Tuncel E.
Assessment of depth of myometrial invasion by endometrial carcinoma: Comparison of
T2-weighted SE and contrast-enhanced dynamic GRE MR imaging.
Eur Radiol.
1998;
8
218-223
- 6
Lee E J, Byun J Y, Kim B, Nam Koon S E, Shinn K S.
Staging of early endometrial carcinoma: Assessment with T2-weighted and gadolinium-enhanced
T1-weighted MR imaging.
Radiographics.
1999;
19
937-945
- 7
DelMaschio A, Vanzuli A, Sironi S, Spagnolo D, Belloni C, Garancini P, Taccagni G L.
Estimating the depth of myometrial involvement by endometrial carcinoma: Efficacy
of transvaginal sonography vs MR imaging.
AJR Am J Roentgenol.
1993;
160
533-538
- 8
Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, Ushijima H,
Ohtake H, Tokunaga T.
Assessment of myometrial invasion by endometrial carcinoma: Transvaginal sonography
vs contrast-enhanced MR imaging.
AJR Am J Roentgenol.
1993;
161
595-599
- 9
Kim S H, Kim H D, Song Y S, Kang S B, Lee H P.
Detection of deep myometrial invasion in endometrial carcinoma: Comparison of transvaginal
ultrasound, CT and MRI.
J Comput Assist Tomogr.
1995;
19
766-772
- 10
Cunha T M, Felix A, Cabral I.
Preoperative assesment of deep myometrial and cervical invasion in endometrial carcinoma:
Comparison of magnetic resonence imaging and gross visual inspection.
Int J Gynecol Cancer.
2001;
11
130-136
- 11
Takahashi S T, Murakami T, Narumi Y, Kurachi H, Tsuda K, Kim T, Enomoto T, Tomoda K,
Murata Y, Nakamura H.
Preoperative staging of endometrial carcinoma: Diagnostic effect of T2-weighted fast
spin-echo MR imaging.
Radiology.
1998;
206
539-547
- 12
Frei K A, Kinkel K.
Staging endometrial cancer: Role of magnetic resonance imaging.
J Magn Reson Imaging.
2000;
13
850-855
- 13
Frei K, Kinkel K, Bonél H M, Lu Y, Zaloudek C, Hricak H.
Prediction of deep myometrial invasion in patients with endometrial cancer: Clinical
Utility of contrast-enhanced MR imaging - A meta-analysis and bayesian analysis.
Radiology.
2000;
216
444-449
- 14
Hardesty L A, Sumkin J H, Nath M E, Edwards R P, Price F V, Chang T S, Johns C M,
Kelley J L.
Use of preoperative MR imaging in the management of endometrial carcinoma: Cost analysis.
Radiology.
2000;
215
45-49
- 15
Larson D M, Johnson K, Olson K A.
Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer:
Morbidity and mortality.
Obstet Gynecol.
1992;
79
998-1001
Prof. Dr. Bernd Hamm
Institut für Radiologie
Universitätsklinikum der Charité
Humboldt-Universität zu Berlin
Schumannstr. 20/21
D-10098 Berlin
Phone: +49-30-450-527031
Fax: +49-30-450-527911
Email: bernd.hamm@charite.de